《大行》大和:敏實(00425.HK)從多個內地主要汽品牌取得訂單 上調目標價至38元
大和報告指,敏實(00425.HK)上半年收入增長11%,略遜該行預期的15%。除電池外殼業務保持高增長,其他業務單位增長緩慢。雖與內地汽車製造商的業務表現良好,但合資企業在華市佔縮減拖累整體表現。海外業務則因電池外殼出貨量強勁而提振,公司幾乎與所有主要歐洲汽車製造商建立合作關係,並有更多產能逐步投入生產。
該行指,公司將全年訂單預訂目標由150億元人民幣上調至160億元人民幣,加大爭取內地汽車製造商在電池外殼和結構底盤部件訂單的努力,併成功從奇瑞、比亞迪、長城汽車和吉利獲得訂單。該行料敏實今年至2027年收入年均複合增長率16%,每股盈利年均複合增長率20%。
該行維持對敏實「買入」評級,目標價由32元上調至38元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.